NCT07127874View on ClinicalTrials.gov

A Study of PHN-012 in Patients With Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

September 23, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

May 31, 2028

Conditions
Colon CancerPancreatic CancerLung Cancer (NSCLC)Advanced CancerAdvanced Solid Tumors
Interventions
DRUG

PHN-012

PHN-012 is an ADC

Trial Locations (3)

22031

RECRUITING

PHN-012-001 Site, Fairfax

37203

RECRUITING

PHN-012-001 Site, Nashville

78229

RECRUITING

PHN-012-001 Site, San Antonio

Sponsors

Lead Sponsor

Pheon Therapeutics
All Listed Sponsors
lead

Pheon Therapeutics

INDUSTRY

NCT07127874 - A Study of PHN-012 in Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter